This difference maybe caused by patient variability because it is reported that EGFR mutations in NSCLC are significantly associated with the female gender and nonsmoking status.77, 83 Another hypothesis is that tumor heterogeneity at the molecular level may be responsible for the difference. The gene discussed is EGFR; the disease is neoplasm.